In order to effectively use cynomolgus monkeys as animal models for human diseases, more than 300 anti-human monoclonal antibodies (mAbs) were studied as to their cross-reaction with various antigens from cynomolgus monkeys (Macaca fascicularis). Two hundred twenty-nine of 339 (67.55%) anti-human mAbs that react with human antigens of CD-defined molecules, chemokine receptors, and T cell receptors were cross-reactive with the monkey antigens. Using the cross-reactive antibodies and the fluorescenced beads for calibration, the procedure for the absolute count of monkey lymphocyte subsets was developed and the mean values for CD4 + and CD8 + lymphocyte subsets in peripheral blood were 718 and 573/mm 3 , respectively. Moreover, intracellular cytokines, IL-2, IL-4 and IFNγ, and intracellular apoptosis-related proteins, Bcl-2, FADD and active form of caspase-3 could be detected in peripheral blood mononuclear cells as well as various tissue cells. It is therefore practicable to detail the phenotype of leukocytes, assess the production of intracellular cytokines and enumerate T-lymphocyte subsets by using the cross-reactive human antibodies with respective antigens of cynomolgus monkeys.
Introduction
Monkeys of the macaque species, which include cynomolgus (Macaca fascicularis), rhesus (Macaca mulatta) and pig-tailed monkey (Macaca nemestrina) are invaluable experimental animals in biomedical re- chronic toxicity of an antiretrovirus [3, 11, 44] , the pathogenesis of infectious diseases [27] , the hematological changes caused by long term exposure to various reagents [45] , the immune dysfunction by viral infections [52] , allogenic transplantation [30, 35] , cancer gene therapy [40] , aging [62] and stress [47] by using the monkey models. These features make macaques unique as models for various human diseases and it becomes possible to understand the mechanisms of pathogenesis and efficacy of a variety of prophylactic and therapeutic agents including vaccines and antiretrovirals by preclinical trials with the monkey models.
For analysis of the animals used in the models, efforts have been made to phenotype the leukocyte and hematopoietic progenitor cells, detection of both red blood cell (RBC) and platelet markers, and detection of intracellular proteins including various cytokines and regulatory molecules. Although some monoclonal antibodies (mAb), e.g. that are specific for the CD3 antigen of cynomolgus monkeys (anti-cynomolgus monkey CD3 mAb, 6G12) [25] or rhesus monkeys (anti-rhesus monkey CD3 mAb, FN18) [36] , were developed, the numbers of available antibodies specific for macaque antigens are too few to study the animals. Recently, anti-human mAbs which were used to define the lineage and function of leukocyte subsets and cytokines in man, have been shown to cross-react with the homologous determinants on macaque antigens by using flow cytometry [2, 19, 32, 39, 43, 50, 53, 58] , immunoprecipitation [2, 7] , bioassay [29, 46] , enzyme-linked immunosorbent assay [23] and immunohistochemistry [31, 54, 63] , but they are still not enough even to determine the distribution of functional details of the subsets of monkey leukocytes. In this study, we evaluated 339 anti-human mAbs for the cross-reactivity with cynomolgus monkey antigens by using three color flow cytometry.
Materials and Methods
Animals: Cynomolgus monkeys kept in the breeding colony of Tsukuba Primate Center, National Institute of Infectious Diseases (NIID), Japan, were used according to the guidelines of the NIID and were free of known simian retroviruses, herpesviruses, bacteria and parasites. The study was conducted with the approval of an institutional committee for P3 level animal experiments and in accordance with the requirements specifically stated in the laboratory biosafety manual of the World Health Organization in the P3 facility for monkeys in Murayama Branch, NIID, Musashimurayama, Tokyo, Japan. Each animal was anesthetized with ketamine (Sankyo Co., Ltd., Tokyo, Japan). Blood samples obtained from healthy cynomolgus monkeys or normal human volunteers were collected by venipuncture with anticoagulant EDTA-2Na or heparin.
Antibodies:
The anti-human mAbs tested in this study are listed in Table 1 . These mAbs were obtained from Beckman Coulter (Miami, FL), Becton Dickinson (San Jose, CA), BioSource (Camarill, CA), Caltag (Burlingame, CA), DAKO (Copenhagen, Denmark), Endogen (Woburn, MA), Nichirei (Tokyo, Japan), Ortho (Raritan, NJ), Pharmingen (San Diego, CA), R&D Systems (Minneapolis, MN), Serotec (Kidlington, Oxford, UK) and Transduction Laboratories (Lexington, KY). For indirect cell staining, unlabeled anti-human mAbs were detected with phycoerythrin (PE)-conjugated goat antimouse IgG mAb (Fab') 2 (Beckman Coulter), PE-conjugated goat anti-mouse IgM mAb (Fab') 2 (Beckman Coulter) or PE-conjugated goat anti-rat IgG mAb (Fab') 2 (Beckman Coulter). All anti-human mAbs were tested at pretitrated concentrations.
Cell preparation and staining: Tissues and peripheral blood were harvested by using a sterile technique and observing appropriate biohazard precautions. Portions of tissues were dissociated to liberate single cells. For cell surface leukocyte antigen analysis, RBC in peripheral blood were lysed by ACK lysis buffer (distilled water with 0.826% of NH 4 Cl, 0.1% of KHCO 3 and 0.0037% of EDTA-2Na, pH 7.3). Peripheral blood was mixed with lysis buffer (peripheral blood: lysis buffer = 1:14) and left for 5 min at room temperature. After centrifugation at 300 × g for 5 min, the cells were washed with PBS and the living cells were counted by a trypan blue dye exclusion method. For platelet preparation, platelet-rich plasma was prepared by centrifugation at 200 × g for 15 min. Bone marrow cells in femur were prepared by lysed RBC. The cells were incubated with each anti-human mAb for 30 min and then washed with staining buffer three times [64] . For activation of PBMC, each 500 µl of hepalinized peripheral blood was placed in a 12 × 75-mm polystyrene tube (Becton Dickinson) and mixed with an appropriate volume of RPMI 1640 medium. Then the diluted samples were incubated with 0.25 µg/ml of phorbol 12-myristate 13-acetate (PMA; Sigma, St. Louis, MO) and 1 µg/ml of ionomycin (Sigma) for 4 hr at 37˚C. Each 100 µl of activated blood sample was incubated with anti-human mAbs for 30 min at room temperature. RBC was lysed with FACS lysing solution (Becton Dickinson) for 10 min at room temperature. All samples were analyzed with a FACSCalibur (Becton Dickinson) equipped with an argon laser tuned at 488 nm and with Cell Quest software (Becton Dickinson).
Absolute counts of peripheral T-lymphocyte by flow cytometry: Monkey peripheral blood was collected with EDTA-2Na. Fifty microliters of blood was placed in a 12 × 75-mm polystyrene tube and stained with FITCconjugated anti-monkey CD3 mAb (FN18; BioSource), PE-conjugated anti-human CD4 mAb (SK3; Becton Dickinson) and peridinin chlorophyll protein (PerCP)-conjugated anti-human CD8 mAb (SK1; Becton Dickinson) for 15 min at 4˚C. The blood was lysed with FACS lysing solution for 15 min at 4˚C. After adding 50 µl of Flow Count (Beckman Coulter), 1 × 10 4 FN18 positive cells were analyzed with a FACSCalibur.
Intracellular cytokine staining: For intracellular cytokine staining, each 500 µl of hepalinized peripheral blood was placed in a 12 × 75-mm polystyrene tube and mixed with an appropriate volume of RPMI 1640 medium. The diluted samples were then incubated with 0.25 µg/ml of PMA, 1 µg/ml of ionomycin and 10 µg/ ml of brefeldin A (Sigma) for 4 hr at 37˚C. Each 100 µl of activated blood sample was incubated with mAbs against cell surface antigens for 30 min at room temperature. RBC was lysed with FACS lysing solution for 10 min at room temperature. The cells were permeabilized with FACS permeabilizing solution (Becton Dickinson) for 10 min at room temperature. After washing three times, the permeabilized cells were incubated with mAbs for cytokine or CD95L (Fas ligand; clone alf-2.1, PE-conjugated) for 30 min at room temperature. All samples were analyzed with a FACSCalibur and Cell Quest software.
Active form of caspase-3 staining: For the active form of caspase-3 staining, T-2 toxin (a trichothecene mycotoxin [59] ), which was kindly donated by Dr. Y. Ueno (Institute of Tochigi Clinical Pathology), was used for the induction of apoptosis [37, 60, 65] . T-2 toxin treated cells were fixed with FACS lysing solution for 10 min at room temperature. The cells were permeabilized by FACS permeabilizing solution for 10 min at room temperature. After washing three times, the permeabilized cells were incubated with PE-conjugated anti-active form of caspase-3 polyclonal Ab for 30 min at room temperature. All samples were analyzed with a FACSCalibur and Cell Quest software.
Apoptosis induction by anti-human CD95 mAbs:
Human and monkey PBMC were isolated by densitygradient centrifugation from heparinaized peripheral blood. PBMC were cultured in RPMI 1640 supplemented with 10% FCS, 5 µg/ml of phytohemagglutinin P (PHA-P; DIFCO Lab., Detroit, MI) and antibiotics for 48 hr. The PHA-stimulated PBMC were cultured with anti-human CD95 mAb (CH11, 7C11 or DX2) 48 hr. By using DX2, the cells were cultured with or without 2 µg/ml of Protein G (Sigma). Apoptotic nuclei were measured by flow cytometry with propidium iodide (PI) staining. The method for quantitative analysis of apoptosis was described previously [64] .
Results

Cross-reactivity of anti-human antibodies with cynomolgus antigens
Three hundred thirty-nine anti-human mAbs from 11 companies were first screened against cynomolgus monkey antigens of CD-defined molecules, chemokine receptors, T cell receptors, intracellular cytokines and intracellular apoptosis-related proteins. In summary, 229 anti-human mAbs (67.55%) were crossreacted with cynomolgus monkey antigens ( Table 1) .
Almost all commercially available mAbs recognizing CD-defined antigens were tested on peripheral blood cells freshly obtained from normal healthy animals. Anti-CD1a and CD41 mAbs reacted with thymocytes and platelets, respectively. Moreover, we found clones of anti-human CD13, CD33, CD34, CD117 (also called c-kit) and CD135 (flt3/flk2) mAbs that reacted with monkey bone marrow cells but did not find cross-reactive anti-human CD33 mAb. Although the clones of anti-human CD102 (ICAM-2) and CD106 (VCAM-1) used in this study were not cross-reactive with monkey endothelial cells from abdominal aorta, those anti-human adhesion molecule mAbs that were noncommercially available were reported to be crossreactive [51, 55] . Furthermore, anti-human CD103 mAbs recognizing human integrin αIEL chain was found to cross-react with mucosal tissue lymphocytes from lamina propria (LPL) and intraepithelium (IEL) in monkey intestines (Fig. 1) . Altogether, although we newly discovered many cross-reactive anti-human CD antibodies by using 339 antibodies in the study, the noncross-reactive CD-defined antigens on the surface of cynomolgus monkey cells still remained to continued to be pursued as a matter of course (Table 1) .
Monoclonal antibodies against human CD19 (J4.119) and CD45RO (UCHL-1) stained weakly with cynomolgus monkey lymphocytes.
And there were non-crossreactive antigens of CD15, CD26, CD33, CD43, CD50, CD57, CD79b, CD152 and CD154. It is of interest that a monkey antigen of CD90 (Thy 1) is expressed on leukocytes (Fig. 2) , but not on human leukocyte. Nevertheless, CD90 was expressed on the surface of hematopoietic stem cells, nerve cells, and high endothelial venule cells of the lymph node in man [12, 57] . In cynomolgus monkey, CD90 was mainly strongly expressed on T-lymphocytes and natural killer (NK) cells and slightly on B-lymphocytes in monkey PBL. And CD56, which is known as the prototypic marker of human NK cells, was expressed on monocytes but not on NK cells [data not shown].
The human mAbs against monkey T cell receptors were screened with peripheral T-lymphocytes from 3 normal cynomolgus monkeys, 5 Mycobacterium bovis bacillus Calmette-Guérin-vaccinated cynomolgus monkeys and 5 hepatitis B virus core antigen-inoculated cynomolgus monkeys. As shown in Table 1 , there were only 18 reactive antibodies out of 34, which seems to be not enough to study the T cell receptor repertoire in the cynomolgus monkey models. On the other hand, almost all chemokine receptors which were screened with PBLs of cynomolgus monkeys cross-react with anti-human chemokine receptor mAbs (Table 1) .
Absolute count of leukocyte subsets using the crossreactive anti-human antibodies
The conventional approach used to obtain an absolute T-cell subset count demands data from two different instruments, i.e. a flow cytometer and a hematology analyzer. With the conventional method, there is the possibility of error accumulation from multiple sources from combined procedures for the cell count. On the other hand, a count procedure which uses calibrated beads with fluorescent properties allows volumetric measurement of T-cell subsets in whole blood and can avoid the error accumulation [10] . With the calibrated beads method, the absolute cell count by flow cytometry was developed and this single-platform absolute cell count technology was applied to monkey studies.
In 68 normal cynomolgus monkeys tested, the CD3 + PBL were gated and the mean of the CD4 + and CD8 + T-lymphocyte counts were 718 ± 286 and 673 ± 362 cells/mm 3 , respectively.
Detection of intracellular cytokines and apoptosis-related proteins in monkeys cells
The recent identification of anti-cytokine mAbs suitable for staining intracellular cytokines has provided the tools for multiparameter flow cytometric analysis of cytokine-producing cells within unseparated cell populations [16, 24, 42] . Staining for one cell surface antigen and two cytoplasmic cytokines has been used to identify and enumerate cell types which express cytokines in a restricted manner, for example Th1 versus Th2 cells, or an unrestricted manner, for example Th0 cells. As shown in Table 2 and Fig. 3 , interleukin-2 (IL-2), IL-4 and interferon-γ (IFNγ) were devised to be detected in PBL of cynomolgus monkey and revealed that IL-2, IFNγ and IL-2/IFNγ were predominant in normal healthy animals, suggesting the Th1 immunological state of the animals. Moreover, detection of intracellular molecules of apoptosis-related proteins such as CD95L (Fig. 4) , Bcl-2 and Fas-associated death domain protein (FADD) was also possible by cross-reacting anti-human mAb with monkey antigens (Table 1) . Caspase-3, recently proved as the major protease in apoptotic signal transduction, was detected as an active form in T-2 toxin induced monkey PBMC [data not shown]. We also tested whether anti-human CD95 mAbs bind to monkey CD95 receptor, because CD95 starts to play a role in the programmed sequence of events leading to cell death by cross-linking with its ligand or some of the mAbs [22, 56] . Monkey PBMCs were stimulated with PHA for 48 hr and the blasted cells were targeted for bindability with anti-human CD95 mAbs, CH11, 7C11 and DX2. As shown in Table 1 , CH11 and 7C11 antibodies did not cross-reacted with monkey PBMC; only DX2 antibody reacted with the monkey PBMC, but the DX2 antibody was not able to induce apoptosis in PHAstimulated monkey PBMC in the presence of protein G, although the antibody induced enhanced apoptosis in human PHA-stimulated PBMC by coculturing the human cells with the antibody in the presence of protein G (data not shown).
Discussion
More than 300 mAbs raised against human leukocyte surface molecules, cytokines or cytoplasmic regulatory molecules have been used to detect antigenically homologous structures of cynomolgus monkey antigens both on the cell surface and in the cytoplasm of PBL and/or other lymphoid tissue cells. We found that approximately 68% of the anti-human mAb tested were positive for crossreactivity with the respective cynomolgus antigens, indicating that leukocyte's subsets can be defined in PBL and various lymphoid tissues of cynomolgus monkeys by selecting the clones of commercially available antibodies. Although the bindability of anti-human antibodies to cynomolgus monkey lymphocytes varies on clones used for the studies, many of the T and B cell determinants on the cell surface were conserved and their immunological phenotypes were able to be defined precisely.
It is of interest that expressions of some antigens on the leukocytes are differently distributed in man and monkeys, e.g. CD90 antigen defined by anti-human CD90 mAb binds to monkey CD3 + lymphocytes, the expression pattern of which is identical with its antigen expression on mouse lymphocytes. In contrast, human CD90 is not expressed on lymphocyte but is on hematopoietic stem cells and nerve cells, and it has been estimated that CD90 may contribute to regulating the proliferation and differentiation of hematopoietic stem cells and memory formation of neurons in the central nervous system. Since CD90 antigen is a signal inducible protein on mouse, the functions of CD90 on monkey leukocytes might be similar to those of mouse CD90, but not to human CD90. CD56 antigen defined by human anti-CD56 mAb was expressed on monocyte in both cynomolgus and rhesus macaques [5] , but not on human monocytes. In man it binds with NK cells that express CD3 -TCR -(α, β, γ, δ) large granular lymphocytes and is co-expressed with CD16 + antigen on the cells [20] .
Though CD19 and CD45RO are major antigens for phenotyping the B cells and memory cells in cynomolgus monkeys, respectively, their antigens are usually stained weakly on the cell surface, and it requires amplification to detect the antigens [15] . Alternatively, their phenotypings were usually studied by using different antibodies, e.g. with CD20 antigens instead of CD19 as a B cell marker and combining CD45RA and CD62L, or CD29 as memory cell marker, which methods are common in monkey studies [4, 8, 33, 49] .
Among the non-crossreactive cynomolgus antigens, some were considered to be important but still remained Since there were no mAbs against monkey CD45 in this study, T-lymphocyte gate, not lymphocyte gate was set by using linear 90° side scatter and log CD3 fluorescence so that the T-lymphocyte purity of the gate becomes close to 100%. Moreover, cynomolgus monkey has significant levels of CD4 and CD8 double positive T-lymphocytes in PBL [1] . It is therefore necessary to stain CD4 and CD8 antigens at the same time.
With this procedure, even low cynomolgus T-lymphocyte counts were accurately determined with the CD3/ CD4/CD8 staining combination. The ability to assess intracellular functional markers by multiparameter flow cytometry offers some unique advantages in analyzing the immune system in monkeys. Cytokines produced by Th1 and Th2 cells play a key role in determining the balance between these two immunologic outcomes and the relationship appears to be important in HIV infection where prior Th1 or Th2 biases influence either initial viral susceptibility or progression to AIDS through immune activation [9, 48] . We made it possible to detect cytokine-producing monkey cells by using the cross-reactive anti-human cytokine Abs. Furthermore, CD95L induces apoptosis via its receptor and is released from the cell surface by matrix metalloproteinases (MMP) like tumor necrosis factor (TNF) [26] , and it is difficult to detect cell surface CD95L directly, without using MMP inhibitor in ex vivo. This detection of CD95L in CD8 + T lymphocytes may become a new index for apoptosis studies and also for detection of frequency of activated cytotoxic T lymphocytes. Moreover, intracellular apoptosis-related proteins, Bcl-2, FADD and an active form of caspase-3 were able to be detected in monkey cells. It therefore seems to be practicable to measure intracellular molecules in vivo in nonhuman primate models by using multicolor flow cytometry.
In the present study anti-human CD95 mAbs were tested for their cross-reactivity. Though DX2 antibody cross-reacted with monkey PBMC and cross-linking with this mAb by protein G delivers an apoptotic signal to human CD95 positive cells [6] , this mAb could not induce apoptosis on PHA-activated monkey lymphocytes. Although it is not clear how this difference in bindability and signal transduction between monkey and man affects the induction of apoptosis, the structure of the functional epitope of monkey CD95 recognized by DX2 antibody might be different from the human to be clarified. For instance, they are CD26 antigen which is an associated marker of autoimmune diseases, adenosine deaminase-deficiency and HIV pathogenesis in humans [18, 38] , CD152 antigen which is proved to be primarily a negative regulator of T cell activation [28] , and p38 (C1.7) antigen which is expressed as a novel signal transduction molecule on human cytotoxic T-lymphocytes [41, 61] . Moreover, only half of the anti-human mAbs against the variable region of T cell receptors were cross-reacted with that of the monkey TCR. In monkey TCR analysis, the combination of cytometric and genetic molecular analysis is now needed to study the T cell receptor repertoire.
On the other hand, antibodies to human chemokine receptors were screened by using monkey peripheral blood leukocytes and it was found that all of tested animals clearly cross-reacted with monkey chemokine receptors. These molecules that are essential for inflammatory or host-defense responses to infections appear to readily cross-react between humans and nonhuman primates. Recently chemokine receptors were reported to serve as coreceptors for the entry of several pathogens, e.g. human immunodeficiency virus (HIV) and plasmodium [13, 14, 21] . From this point of view, a cross-reactive study of the antigenicity of the molecules demonstrates that many monkey responses are analogous to human responses, which suggests that the monkey is suitable as a model animal for biological responses or diseases in humans.
With regard to the absolute counts of leukocytes, non-human primate models have been developed to study infectious diseases, and accurate counting of leukocytes subsets is crucial to understanding the infection of pathogens, such as simian/human immunodeficiency virus (SHIV). In HIV-infected individuals, the CD4 + T-lymphocyte count is one of the important markers for determining disease progression [17] and the procedure for enumeration of human CD4 and CD8 T-lymphocyte was recently developed with the recommendation that the panel should be a three color combination requiring two tubes. They were with CD45/CD3/CD4 and CD45/CD3/CD8 for three color protocols [34] . In this protocol, lymphocyte gate was set by using linear 90° side scatter and log CD45 fluorescence and then lymphocytes were defined as CD45 bright with low side scatter. In this study, we developed an absolute count procedure for monkeys.
epitope.
Altogether although non-crossreactive antigens and some differences in biological actions of mAbs on monkey cells remain, it is practicable to use the cross-reactive human mAbs with cynomolgus antigens by upgrading multicolor flow cytometric analysis in non-human primate models. The methods are effective for detailing the phenotype of leukocytes, detecting the production of intracellular cytokines and enumerating T-lymphocyte subsets.
